ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the income earned by banks from the fund they have on their balance sheet. Alexion Pharmaceuticals Inc's net interest income for the three months ended in Mar. 2014 was $1 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2014 was $1 Mil.
Alexion Pharmaceuticals Inc's quarterly net interest income increased from Sep. 2013 ($-0 Mil) to Dec. 2013 ($1 Mil) and increased from Dec. 2013 ($1 Mil) to Mar. 2014 ($1 Mil).
Alexion Pharmaceuticals Inc's annual net interest income declined from Dec. 2011 ($1 Mil) to Dec. 2012 ($-6 Mil) but then increased from Dec. 2012 ($-6 Mil) to Dec. 2013 ($-1 Mil).
Income earned by banks from the fund they have on their balance sheet. These funds can be from customers' deposit, bank's own equity or borrowed.
Alexion Pharmaceuticals Inc Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2014 was -0.338 (Jun. 2013 ) + -0.44 (Sep. 2013 ) + 0.746 (Dec. 2013 ) + 1.15 (Mar. 2014 ) = $1 Mil.
Alexion Pharmaceuticals Inc Annual Data
Alexion Pharmaceuticals Inc Quarterly Data